Dyadic to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
JUPITER, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein production and unmet clinical needs for effective and affordable biopharmaceutical products for human and animal health, today announced that it will report its financial results for the third quarter 2022 and host a corporate update conference call on Thursday, November 10, 2022.
Related news for (DYAI)
- Today’s Top Performers: MoBot’s Market Review 07/23/25 07:00 PM
- Breaking News: MoBot’s Latest Update as of 07/23/25 06:00 PM
- Today’s Top Performers: MoBot’s Market Review 07/23/25 05:00 PM
- Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
- Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference